INSIGHTS ON DRUG DEVELOPMENT
-
In Vitro Drug Screening On Cancer Cells
Explore a high-throughput assay combining stain-free imaging and multiplexed viability/toxicity measurements to evaluate drug effects on cancer cells, ideal for labs optimizing cell-based screening.
-
Aggregation In Antibody-Drug Conjugates: Causes And Mitigation
Discover how early intervention in ADC development can streamline clinical progress, ensure stability and safety, and accelerate commercialization with expert guidance.
-
Neoantigen-Based Personalized Cancer Vaccine
Personalized cancer vaccines are advancing quickly, but effective delivery remains a major hurdle. Learn how mRNA and lipid nanoparticle design influence targeting, endosomal escape, and repeat dosing.
-
Advancing Cell Therapies With Lipid Nanoparticles
Cell therapies, using reprogrammed immune cells, offer innovative treatments for diseases. Discover how lipid nanoparticles (LNPs) enhance these therapies by delivering RNA for gene modulation and next-gen treatments.
-
Patient-Centric Formulations In Pediatric Adherence11/13/2025
Improving pediatric adherence requires age-appropriate formulations, taste-masking, and swallowability strategies. Regulatory, clinical, and technological insights help overcome barriers and support safer, more effective therapies for children across developmental stages.
-
An Alternative Method Of Drug-Excipient Characterization12/30/2024
Isothermal microcalorimetry (IMC) rapidly screens API-excipient compatibility, detecting physical and chemical interactions faster than conventional methods, saving time and effort in pharmaceutical formulation development.
-
Measuring Thermodynamic Parameters In The Drug Development Process4/29/2025
Join Dr. Ladbury to explore how thermodynamic data can enhance our understanding of protein-ligand interactions and how it is crucial for optimizing drug efficacy and safety in pharmaceutical development.
-
How Do You Start Process Transfer For A New Client?7/23/2026
Anmaris Torres, Process Engineering Team Leader, on why a process transfer starts with a conversation across departments to figure out how to cut cycle time before commercial production begins.
-
Key Metrics In Antibody Drug Development6/26/2025
Explore key techniques like DSC and Rheology to assess thermal stability and viscosity in antibody drug development. Gain practical insights to enhance biologic candidate selection, formulation, and delivery.
DRUG DEVELOPMENT SOLUTIONS
-
Encoded stereo microscopes Leica M165 C - Total recall of your settings
Your goal: high-quality images that allow measurements and can be accurately repeated with minimal effort. The Leica coded stereo microscopes help you to pave the way to correct results.
-
Coded microscopes consistently deliver calibrated and comparable images
-
Reproduce images in moments with the Leica “Store and Recall” function
-
Fully apochromatic corrected zoom optics deliver high quality images
-
Customize the microscope system to your task with the exclusive range of accessories
-
-
3D organoids offer enhanced physiological relevance and are ready to use from cryopreserved vials. Discover how they can streamline your research with high-quality and comprehensive support.
-
Enhance drug solubility and bioavailability with an advanced mesoporous silica excipient that stabilizes poorly soluble compounds in their amorphous form and is backed by strong regulatory and quality support.
-
Cell DIVE Multiplex Imaging Solution
What if every scientist could map normal and diseased tissue by cell type, biomarker profile, and specific features?
Cell DIVE is a precise, open multiplexing solution that lets your research dictate the level of automation required, which antibodies to use, how to build your antibody panel, and more.
-
SimpleStep ELISA® kits are sandwich ELISA assays that we have developed to be as simple and effective as possible. Unlike traditional sandwich ELISAs, which take more than three hours to run, SimpleStep ELISA kits generate data in just 90 minutes without compromising performance, using only one wash step and recombinant antibodies for exceptional specificity.